International Journal of Endocrinology / 2014 / Article / Tab 3

Clinical Study

Response to Initial Therapy of Differentiated Thyroid Cancer Predicts the Long-Term Outcome Better than Classical Risk Stratification Systems

Table 3

Clinical endpoints for each risk stratification system.

ETAATARIT
Low 
( )
High 
( )
Low 
( )
Intermediate 
( )
High 
( )
Excellent 
( )
Acceptable 
( )
Incomplete 
( )

No evidence of disease after initial therapy87.9% (87)51.9% (40)91.8% (90)51.4% (36)12.5% (1)97.7% (125)10.5% (2)0% (0)

No evidence of disease after additional therapy6.1% (6)7.8% (6)3.1% (3)11.4% (8)12.5% (1)0% (0)21.1% (4)27.6% (8)

Persistent biochemical disease5.1% (5)26% (20)4.1% (4)25.7% (18)37.5% (3)2.3% (3)63.2% (12)34.5% (10)

Persistent structural disease1% (1)11.7% (9)1% (1)11.4% (8)12.5% (1)0% (0)5.3% (1)31% (9)

Disease specific mortality0% (0)2.6% (2)0% (0)0% (0)25% (2)0% (0)0% (0)6.9% (2)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.